Moradi, A., Dizman, N., Ebrahimi, H., Qi, X., Gomes, A. C., Zugman, M., Jaime-Casas, S., Goes, V. A. D., Li, X., Dorff, T. B., Hsu, J., Chehrazi-Raffle, A., Takahashi, M., Oka, K., Higashi, S., Lee, P. P., Parks, T. P., Karmouch, J., Jeng, R., Pal, S. K. (2026). Long-term clinical outcomes with
                    <i>Clostridium butyricum</i>
                    MIYAIRI 588 (CBM588) and TOPOSCORE assessment in patients receiving immune checkpoint inhibitor (ICI)-based combinations for metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.507